Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NKS-3 in obese adults
NCT07882654Phase 2Not yet recruiting
- Sponsor
- EktaH
- Start
- Oct 2026
- Primary completion
- Feb 2027
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of NKS-3 in obesity, sponsored by EktaH. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
NKS-3
03
Conditions
obesity
Beyond the preview
Go deeper on NCT07882654.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07882654.